Naperville, IL -- (SBWire) -- 09/12/2013 --Reportstack, provider of premium market research reports announces the addition of EpiCast Report: Acne - Epidemiology Forecast to 2022 market report to its offering
EpiCast Report: Acne - Epidemiology Forecast to 2022

Summary

Acne vulgaris (acne) is an inflammatory skin disease that affects nearly all adolescents and adults at some point in their lives. The clinical presentation of acne ranges from a mild comedonal form to severe inflammatory cystic acne of the face, chest, and back. Globally, acne has a lifetime prevalence of over 90% in people of all ages, and a point-prevalence of approximately 85% in the population ages 1524 years._x000D_

epidemiological analysis forecasts an increase in the total prevalent cases of acne in people ages 1044 years in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK), from 103.91 million prevalent cases in 2012 to 105.46 million prevalent cases in 2022, with a decadal growth rate of 1.5%. As GlobalData epidemiologists used steady prevalence proportions of acne over the forecast period, the growth in prevalent cases in each market can be attributed to the change in population demographics in people ages 1044 years in the respective markets._x000D_

Although acne is not a life-endangering condition, it is associated with a huge psychosocial impact and economic burden. epidemiological forecast emphasizes the need for preventive measures that are directed towards high-risk groups and signifies the need for early intervention with the available effective treatments in order to tackle the increasing burden of acne.

GlobalData epidemiologists forecast the prevalent cases of acne in the 6MM from 20122022 using nationally-representative, country-specific studies published in peer-reviewed journals that provided the age- and sex-specific prevalence of acne in the 6MM. Additionally, they further segmented the total prevalent cases of acne by severity. GlobalData epidemiologists ensured that the forecast methodology was consistent across all the 6MM to allow for a meaningful comparison of the total prevalent cases of acne across these markets.

Scope

- The Acne EpiCast Report provides an overview of the risk factors and global trends of acne in the 6MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast of acne prevalent cases segmented by age (in five-year increments beginning at age 0 and ending at age 44 years), sex, and stage in these six markets.
- The acne epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global acne market._x000D_
- Quantify patient populations in the global acne market to improve product design, pricing, and launch plans._x000D_
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne therapeutics in each of the markets covered._x000D_
- Identify the percentage of acne prevalent cases by stage.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/141548/epicast-report-acne-epidemiology-forecast-to-2022.html